期刊文献+

糖肾方对2型糖尿病肾病模型OLETF大鼠IL-10、TNF-α、DA调控作用观察 被引量:12

Protective Effect of Tangshen Formula on Renal function and IL-10、TNF-α、DA in OLETF Rats
暂未订购
导出
摘要 目的:探讨糖肾方对自发性2型糖尿病模型OLETF大鼠肾脏的保护作用以及对血中白细胞介素-10、肿瘤坏死因子-α和多巴胺的影响。方法:OLETF大鼠随机分为模型组、糖肾方组(1.6g/kg)、蒙诺组(1.0mg/kg)、LETO大鼠为正常对照组。各组动物从12周龄起进行灌胃给药,连续给药44周。实验结束,大鼠56周龄时,测定血糖和24h尿蛋白水平、血清中白细胞介素-10、肿瘤坏死因子-α、多巴胺。取肾组织观察肾组织形态学改变,并对肾损害进行半定量评分。结果:糖肾方可降低模型组大鼠血中TNF-α、DA水平,升高IL-10水平。降低肾小球硬化指数和肾小管间质纤维化指数,改善肾组织形态学异常。结论:糖肾方对2型糖尿病模型OLETF大鼠肾脏具有保护作用,延缓其病理进展,其作用机制可能与调节体内炎症因子水平有关。 Objective:To observe the renal protective effect of Tangshen Formula(TF) in the spontaneous rat model of type 2 diabetic nephropathy-OLETF rats and explore the possible molecular mechanism. Methods:OLETF rats were randomly divided into three groups: model group, TF group(1.6 g/kg) and monopril group(1.0 mg/kg).LETO rats with the same week age and sex were used as control group. Tangshen Formula was given to the relevant group after 12 week for 44 weeks by intragastric administration. Levels of blood glucose and 24 hours urinary protein were determined every 4 weeks. When the trial was finished, blood samples were taken from the abdominal aorta and TNF-α, IL-10 and DA in blood serum were detected. Kidney tissue was taken for histopathological and pathological change of glomeruli and interstitial of nephric tubule were observed by semiquantitative assessment. Results:Comparing with the model group, TF group decreased the levels of TNF-α and DA, as well as golmerulosclerossi index and tubular fibrosis index, increased the level of IL-10. Conclusion:Tangshen Formula has a good renal protective effect in rats with diabetic nephropathy. The mechanism may be partly related to inhibiting the inflammatory cytokine expression.
出处 《中国中西医结合肾病杂志》 2011年第12期1044-1047,I0010,共5页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 国家自然科学基金资助项目(No.30973911 30801539)
关键词 糖肾方 糖尿病肾病 OLETF大鼠 白细胞介素-10 肿瘤坏死因子-α 多巴胺 Tangshen formula Diabetic nephropathy OLETF Inter leukin-10 Tumor necrosis factor-α DA
  • 相关文献

参考文献9

  • 1刘海霞,孙李永隽,刘奔,刘丹丹,李晶,张萍,王荔,刘佳,王黎,孟秀香,苏本利.阿卡波糖对2型糖尿病患者慢性炎症相关因子水平的影响[J].中华内分泌代谢杂志,2011,27(3):193-198. 被引量:24
  • 2Thallas-bonke V,Thorpe SR,Coughlan MT,et al.Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.Diabetes,2008,57(2):460-469.
  • 3Sebekova K,Eifert T,Klassen A,et al.Renal effects of S18886 (Terutroban),a TP receptor antagonist,in an experimental model of type 2 diabetes.Diabetes,2007,56(4):968-974.
  • 4Veniant M,Heudes D,Clozel JP,et al.Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats.Kidney Int,1994,46(2):421-429.
  • 5Fornoni A,Tejada IA.Role of inflammation in diabetic nephropathy.Curr Diabetes,2008,4(1):10-17.
  • 6Tsiotra PC,Tsigos C,Yfanti E,et al.Visfatin,TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women.Horm Metab Res,2007,39 (10):758-763.
  • 7Mtiraoui N,Ezzidi I,Kacem M,et al.Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.Diabetes Metab Res Rev,2009,25(1):57-63.
  • 8Kung WJ,Lin CC,Liu SH,et al.Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy.Diabetes Technol Ther,2010,12(10):809-813.
  • 9Jeschke MG,Einspanier R,Klein D,et al.Insulin attenuates the systemic inflammatory response to thermal trauma.Mol Med,2002,8(8):443-450.

二级参考文献36

  • 1Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China.N Engl J Med,2010,362:1090-1101.
  • 2Wellen KE,Hotamisligil GS.Inflammation,stress,and oxidative stress.J Clin Invest,2005,115:1111-1119.
  • 3Yudkin JS.Insulin resistance and the metabolic syndrome-or the pitfalls of epidemiology.Diabetologia,2007,50:1576-1586.
  • 4Pickup JC,Mattock MB,Chusney GD,et al.NIDDM as a disease of the innate immune system:association of acute-phase reactants and interleukin-6 with metabolic syndrome.Diabetologia,1997,40:1286-1292.
  • 5Barzilay JI,Abraham L,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly.Diabetes,2001,50:2384-2389.
  • 6Kajitani N,Shikata K,Nakamura A,et al.Microinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.Diabetes Res Clin Pract,2010,88:171-176.
  • 7Chiasson JL,Josse RG,Hanefeld M,et al.Acarbose treatment and the risk of cardiovascular disease and hypertension in parients with impaired glucose tolerance-The STOP-NIDDM.JAMA,2003,290:486-494.
  • 8Hanefeld M,Cagatay M,Petrowitsch T,et al.Acarbose reduces the risk of myocardial infraction in type 2 diabetic patients:meta-analysis of seven long-term studies.Eur Heart J,2004,25:10-16.
  • 9Shimazu T,Inami N,Satoh D,et al.Effect of acarbose on plateletderived microparticles,soluble selectins,and adiponectin in diabetic patients.J Thromb Thrombolysis,2009,28:429-435.
  • 10Hanefeld M,Schaper F,Koehler C,et al.Effect of acarbose on postmeal mononuclear blood cell response in oatients with early type 2 diabetes:the AI(Ⅰ) DA study.Horm Metab Res,2009,41:132-136.

共引文献23

同被引文献267

引证文献12

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部